Close X
Attorney Spotlight

How does Jessie Zeigler anticipate the intersection of privacy and smart technology will impact the future of litigation? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Primary Care Providers Win Challenge of CMS Interpretation of Enhanced Payment Law

With the help and support of the Tennessee Medical Association, 21 Tennessee physicians of underserved communities joined together and retained Bass, Berry & Sims to file suit against the Centers for Medicare & Medicaid Services to stop improper collection efforts. Our team, led by David King, was successful in halting efforts to recoup TennCare payments that were used legitimately to expand services in communities that needed them. Read more

Tennessee Medical Association & Bass, Berry & Sims

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

GDPR Top 5 Actions You Should Take Now

The EU's General Data Protection Regulation (GDPR) went into effect on May 25th. As most organizations are aware, the GDPR applies not only to EU businesses but also many companies in the U.S. While the deadline is quickly approaching, most organizations are still grappling with the implications of the regulation on their business. Even if your readiness efforts are behind the curve, the GDPR Top 5 Actions You Should Take NOW will help you begin your efforts towards compliance and help mitigate your organization's risk in the short-term.

Click here to download the checklist.

AxelaCare CON Approved for Middle Tennessee Region

Client Type: Private Company

Bass, Berry & Sims served as lead counsel to AxelaCare Health Solutions LLC – a subsidiary of United Health Group – in its efforts to obtain a Certificate of Need (CON) to initiate homecare operations in 40 counties in and around metropolitan Nashville, Tennessee. The project received wide support – including from Meharry Medical College – and was unanimously approved by state regulators. The addition of AxelaCare's services in Middle Tennessee will make highly specialized immune globulin infusion therapy available at home to seriously ill patients suffering from very rare cancers and chronic immunological and neurological disorders. Researchers across the United States use data collected via AxelaCare's proprietary patient care technology in a wide variety of clinical research.

AxelaCare specializes in specialty infusion therapy homecare services. Its nursing specialists have performed more than 44,000 infusion therapy sessions in recent years. AxelaCare has received the Joint Commission's "Gold Seal" of approval and is recognized for meeting the highest clinical standards in the industry.

You Also May Be Interested In:

Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.